Insulin action and resistance in obesity and type 2 diabetes (original) (raw)
1. Reaven GM. The insulin resistance syndrome: definition and dietary approaches to treatment. Annu Rev Nutr. 2005;25:391–406. [PubMed] [Google Scholar]
2. National Diabetes Statistics Report. 2014 www.CDC.gov.
3. Kloting N, et al. Insulin-sensitive obesity. Am J Physiol Endocrinol Metab. 2010;299:E506–515. [PubMed] [Google Scholar]
4. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care. 1992;15:318–368. [PubMed] [Google Scholar]
5. Kim SH, Reaven GM. Insulin resistance and hyperinsulinemia: you can’t have one without the other. Diabetes Care. 2008;31:1433–1438. [PMC free article] [PubMed] [Google Scholar]
6. McGarry JD. What if Minkowski had been ageusic? An alternative angle on diabetes. Science. 1992;258:766–770. [PubMed] [Google Scholar]
7. Shanik MH, et al. Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse? Diabetes Care. 2008;31(Suppl 2):S262–268. [PubMed] [Google Scholar]
8. Pories WJ, Dohm GL. Diabetes: have we got it all wrong? Hyperinsulinism as the culprit: surgery provides the evidence. Diabetes Care. 2012;35:2438–2442. [PMC free article] [PubMed] [Google Scholar]
10. Boucher J, Kleinridders A, Kahn CR. Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb Perspect Biol. 2014;6 [PMC free article] [PubMed] [Google Scholar]
11. Parker VE, Savage DB, O’Rahilly S, Semple RK. Mechanistic insights into insulin resistance in the genetic era. Diabet Med. 2011;28:1476–1486. [PubMed] [Google Scholar]
13. Ryder JW, Gilbert M, Zierath JR. Skeletal muscle and insulin sensitivity: pathophysiological alterations. Front Biosci. 2001;6:D154–163. [PubMed] [Google Scholar]
14. Pendergrass M, et al. Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individuals. Am J Physiol Endocrinol Metab. 2007;292:E92–100. [PubMed] [Google Scholar]
15. Nakae J, Barr V, Accili D. Differential regulation of gene expression by insulin and IGF-1 receptors correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR. EMBO J. 2000;19:989–996. [PMC free article] [PubMed] [Google Scholar]
16. Gross DN, van den Heuvel AP, Birnbaum MJ. The role of FoxO in the regulation of metabolism. Oncogene. 2008;27:2320–2336. [PubMed] [Google Scholar]
17. Titchenell PM, et al. Direct Hepatocyte Insulin Signaling Is Required for Lipogenesis but Is Dispensable for the Suppression of Glucose Production. Cell Metab. 2016;23:1154–1166. [PMC free article] [PubMed] [Google Scholar]
18. Qu S, et al. Aberrant Forkhead box O1 function is associated with impaired hepatic metabolism. Endocrinology. 2006;147:5641–5652. [PMC free article] [PubMed] [Google Scholar]
19. Ozcan L, et al. Calcium signaling through CaMKII regulates hepatic glucose production in fasting and obesity. Cell Metab. 2012;15:739–751. [PMC free article] [PubMed] [Google Scholar]
20. Banks AS, et al. Dissociation of the glucose and lipid regulatory functions of FoxO1 by targeted knockin of acetylation-defective alleles in mice. Cell Metab. 2011;14:587–597. [PMC free article] [PubMed] [Google Scholar]
21. Zhang W, et al. FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression. J Biol Chem. 2006;281:10105–10117. [PubMed] [Google Scholar]
22. Perry RJ, et al. Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell. 2015;160:745–758. [PMC free article] [PubMed] [Google Scholar]
23. Cherrington AD, Edgerton D, Sindelar DK. The direct and indirect effects of insulin on hepatic glucose production in vivo. Diabetologia. 1998;41:987–996. [PubMed] [Google Scholar]
24. Rebrin K, Steil GM, Mittelman SD, Bergman RN. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. J Clin Invest. 1996;98:741–749. [PMC free article] [PubMed] [Google Scholar]
25. Schoiswohl G, et al. Impact of Reduced ATGL-Mediated Adipocyte Lipolysis on Obesity-Associated Insulin Resistance and Inflammation in Male Mice. Endocrinology. 2015;156:3610–3624. [PMC free article] [PubMed] [Google Scholar]
26. Kimmel AR, Sztalryd C. The Perilipins: Major Cytosolic Lipid Droplet-Associated Proteins and Their Roles in Cellular Lipid Storage, Mobilization, and Systemic Homeostasis. Annu Rev Nutr. 2016;36:471–509. [PubMed] [Google Scholar]
27. Puri V, et al. Cidea is associated with lipid droplets and insulin sensitivity in humans. Proc Natl Acad Sci U S A. 2008;105:7833–7838. [PMC free article] [PubMed] [Google Scholar]
28. Gandotra S, et al. Perilipin deficiency and autosomal dominant partial lipodystrophy. N Engl J Med. 2011;364:740–748. [PMC free article] [PubMed] [Google Scholar]
29. Rubio-Cabezas O, et al. Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC. EMBO Mol Med. 2009;1:280–287. [PMC free article] [PubMed] [Google Scholar]
30. Zhou L, et al. Insulin resistance and white adipose tissue inflammation are uncoupled in energetically challenged Fsp27-deficient mice. Nat Commun. 2015;6:5949. [PMC free article] [PubMed] [Google Scholar]
31. Lotta LA, et al. Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance. Nat Genet. 2017;49:17–26. [PMC free article] [PubMed] [Google Scholar]
32. Tran TT, Yamamoto Y, Gesta S, Kahn CR. Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab. 2008;7:410–420. [PMC free article] [PubMed] [Google Scholar]
33. Min SY, et al. Human ‘brite/beige’ adipocytes develop from capillary networks, and their implantation improves metabolic homeostasis in mice. Nat Med. 2016;22:312–318. [PMC free article] [PubMed] [Google Scholar]
34. Biddinger SB, et al. Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. Cell Metab. 2008;7:125–134. [PMC free article] [PubMed] [Google Scholar]
35. Brown MS, Goldstein JL. Selective versus total insulin resistance: a pathogenic paradox. Cell Metab. 2008;7:95–96. [PubMed] [Google Scholar]
36. Caron A, Richard D, Laplante M. The Roles of mTOR Complexes in Lipid Metabolism. Annu Rev Nutr. 2015;35:321–348. [PubMed] [Google Scholar]
37. Bar-Peled L, Sabatini DM. Regulation of mTORC1 by amino acids. Trends Cell Biol. 2014;24:400–406. [PMC free article] [PubMed] [Google Scholar]
38. Beck-Nielsen H. The role of glycogen synthase in the development of hyperglycemia in type 2 diabetes: ‘To store or not to store glucose, that’s the question’ Diabetes Metab Res Rev. 2012;28:635–644. [PubMed] [Google Scholar]
39. Beck-Nielsen H, Henriksen JE, Vaag A, Hother-Nielsen O. Pathophysiology of non-insulin-dependent diabetes mellitus (NIDDM) Diabetes Res Clin Pract. 1995;28(Suppl):S13–25. [PubMed] [Google Scholar]
40. Nolan CJ, Ruderman NB, Kahn SE, Pedersen O, Prentki M. Insulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetes. Diabetes. 2015;64:673–686. [PMC free article] [PubMed] [Google Scholar]
41. Corkey BE. Diabetes: have we got it all wrong? Insulin hypersecretion and food additives: cause of obesity and diabetes? Diabetes Care. 2012;35:2432–2437. [PMC free article] [PubMed] [Google Scholar]
42. Erion KA, Berdan CA, Burritt NE, Corkey BE, Deeney JT. Chronic Exposure to Excess Nutrients Left-shifts the Concentration Dependence of Glucose-stimulated Insulin Secretion in Pancreatic beta-Cells. J Biol Chem. 2015;290:16191–16201. [PMC free article] [PubMed] [Google Scholar]
43. Kim MK, Reaven GM, Chen YD, Kim E, Kim SH. Hyperinsulinemia in individuals with obesity: Role of insulin clearance. Obesity (Silver Spring) 2015;23:2430–2434. [PMC free article] [PubMed] [Google Scholar]
44. Kobayashi M, Olefsky JM. Effect of experimental hyperinsulinemia on insulin binding and glucose transport in isolated rat adipocytes. Am J Physiol. 1978;235:E53–62. [PubMed] [Google Scholar]
45. Soop M, et al. Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans. Am J Physiol Endocrinol Metab. 2002;282:E1276–1285. [PubMed] [Google Scholar]
46. Siklova-Vitkova M, et al. Effect of hyperinsulinemia and very-low-calorie diet on interstitial cytokine levels in subcutaneous adipose tissue of obese women. Am J Physiol Endocrinol Metab. 2009;297:E1154–1161. [PubMed] [Google Scholar]
47. Murdolo G, et al. Monocyte chemoattractant protein-1 in subcutaneous abdominal adipose tissue: characterization of interstitial concentration and regulation of gene expression by insulin. J Clin Endocrinol Metab. 2007;92:2688–2695. [PubMed] [Google Scholar]
48. Westerbacka J, et al. Acute in vivo effects of insulin on gene expression in adipose tissue in insulin-resistant and insulin-sensitive subjects. Diabetologia. 2006;49:132–140. [PubMed] [Google Scholar]
49. Westerbacka J, et al. Insulin regulation of MCP-1 in human adipose tissue of obese and lean women. Am J Physiol Endocrinol Metab. 2008;294:E841–845. [PubMed] [Google Scholar]
50. Krogh-Madsen R, Plomgaard P, Keller P, Keller C, Pedersen BK. Insulin stimulates interleukin-6 and tumor necrosis factor-alpha gene expression in human subcutaneous adipose tissue. Am J Physiol Endocrinol Metab. 2004;286:E234–238. [PubMed] [Google Scholar]
51. Jansen HJ, et al. Start of insulin therapy in patients with type 2 diabetes mellitus promotes the influx of macrophages into subcutaneous adipose tissue. Diabetologia. 2013;56:2573–2581. [PubMed] [Google Scholar]
52. Lackey DE, Olefsky JM. Regulation of metabolism by the innate immune system. Nat Rev Endocrinol. 2016;12:15–28. [PubMed] [Google Scholar]
53. Tsiotra PC, Boutati E, Dimitriadis G, Raptis SA. High insulin and leptin increase resistin and inflammatory cytokine production from human mononuclear cells. Biomed Res Int. 2013;2013:487081. [PMC free article] [PubMed] [Google Scholar]
54. Pedersen DJ, et al. A major role of insulin in promoting obesity-associated adipose tissue inflammation. Mol Metab. 2015;4:507–518. [PMC free article] [PubMed] [Google Scholar]
55. Roth Flach RJ, et al. Protein Kinase Mitogen-activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4) Promotes Obesity-induced Hyperinsulinemia. J Biol Chem. 2016;291:16221–16230. [PMC free article] [PubMed] [Google Scholar]
56. Boden G, Chen X, Rosner J, Barton M. Effects of a 48-h fat infusion on insulin secretion and glucose utilization. Diabetes. 1995;44:1239–1242. [PubMed] [Google Scholar]
57. Stein DT, et al. Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat. J Clin Invest. 1996;97:2728–2735. [PMC free article] [PubMed] [Google Scholar]
58. Deeney JT, et al. Acute stimulation with long chain acyl-CoA enhances exocytosis in insulin-secreting cells (HIT T-15 and NMRI beta-cells) J Biol Chem. 2000;275:9363–9368. [PubMed] [Google Scholar]
59. Templeman NM, Clee SM, Johnson JD. Suppression of hyperinsulinaemia in growing female mice provides long-term protection against obesity. Diabetologia. 2015;58:2392–2402. [PMC free article] [PubMed] [Google Scholar]
60. Mehran AE, et al. Hyperinsulinemia drives diet-induced obesity independently of brain insulin production. Cell Metab. 2012;16:723–737. [PubMed] [Google Scholar]
61. D’Souza AM, Johnson JD, Clee SM, Kieffer TJ. Suppressing hyperinsulinemia prevents obesity but causes rapid onset of diabetes in leptin-deficient Lepob/ob mice. Mol Metab. 2016;5:1103–1112. [PMC free article] [PubMed] [Google Scholar]
62. Nedergaard J, Cannon B. The browning of white adipose tissue: some burning issues. Cell Metab. 2014;20:396–407. [PubMed] [Google Scholar]
63. Liu D, et al. Activation of mTORC1 is essential for beta-adrenergic stimulation of adipose browning. J Clin Invest. 2016;126:1704–1716. [PMC free article] [PubMed] [Google Scholar]
64. Marban SLRJ. In: Transgenic hyperinsulinemia: a mouse model of insulin resistance and glucose intolerance without obesity. Shafrir E, editor. Boston: Birkhauser; 1996. [Google Scholar]
65. Pontiroli AE, Alberetto M, Capra F, Pozza G. The glucose clamp technique for the study of patients with hypoglycemia: insulin resistance as a feature of insulinoma. J Endocrinol Invest. 1990;13:241–245. [PubMed] [Google Scholar]
66. Manousaki D, et al. Toward Precision Medicine: TBC1D4 Disruption Is Common Among the Inuit and Leads to Underdiagnosis of Type 2 Diabetes. Diabetes Care. 2016 [PubMed] [Google Scholar]
67. Chen DL, et al. Phenotypic Characterization of Insulin-Resistant and Insulin-Sensitive Obesity. J Clin Endocrinol Metab. 2015;100:4082–4091. [PubMed] [Google Scholar]
68. Waise TM, et al. One-day high-fat diet induces inflammation in the nodose ganglion and hypothalamus of mice. Biochem Biophys Res Commun. 2015;464:1157–1162. [PubMed] [Google Scholar]
69. Turner N, et al. Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding. Diabetologia. 2013;56:1638–1648. [PubMed] [Google Scholar]
70. Scherer T, et al. Short term voluntary overfeeding disrupts brain insulin control of adipose tissue lipolysis. J Biol Chem. 2012;287:33061–33069. [PMC free article] [PubMed] [Google Scholar]
71. Paglialunga S, Ludzki A, Root-McCaig J, Holloway GP. In adipose tissue, increased mitochondrial emission of reactive oxygen species is important for short-term high-fat diet-induced insulin resistance in mice. Diabetologia. 2015;58:1071–1080. [PubMed] [Google Scholar]
72. Barzel B, et al. Short term fat feeding rapidly increases plasma insulin but does not result in dyslipidaemia. Front Physiol. 2014;5:469. [PMC free article] [PubMed] [Google Scholar]
73. Ji Y, et al. Short term high fat diet challenge promotes alternative macrophage polarization in adipose tissue via natural killer T cells and interleukin-4. J Biol Chem. 2012;287:24378–24386. [PMC free article] [PubMed] [Google Scholar]
74. Lee YS, et al. Inflammation is necessary for long-term but not short-term high-fat diet-induced insulin resistance. Diabetes. 2011;60:2474–2483. [PMC free article] [PubMed] [Google Scholar]
75. Ben-Shlomo S, et al. Perinephric and epididymal fat affect hepatic metabolism in rats. Obesity (Silver Spring) 2012;20:151–156. [PubMed] [Google Scholar]
76. Commerford SR, et al. Diets enriched in sucrose or fat increase gluconeogenesis and G-6-Pase but not basal glucose production in rats. Am J Physiol Endocrinol Metab. 2002;283:E545–555. [PubMed] [Google Scholar]
77. Boden G, et al. Excessive caloric intake acutely causes oxidative stress, GLUT4 carbonylation, and insulin resistance in healthy men. Sci Transl Med. 2015;7:304re307. [PMC free article] [PubMed] [Google Scholar]
78. Brons C, et al. Impact of short-term high-fat feeding on glucose and insulin metabolism in young healthy men. J Physiol. 2009;587:2387–2397. [PMC free article] [PubMed] [Google Scholar]
79. Lagerpusch M, Bosy-Westphal A, Kehden B, Peters A, Muller MJ. Effects of brief perturbations in energy balance on indices of glucose homeostasis in healthy lean men. Int J Obes (Lond) 2012;36:1094–1101. [PubMed] [Google Scholar]
80. Olefsky J, Crapo PA, Ginsberg H, Reaven GM. Metabolic effects of increased caloric intake in man. Metabolism. 1975;24:495–503. [PubMed] [Google Scholar]
81. Wadden D, et al. Serum acylated ghrelin concentrations in response to short-term overfeeding in normal weight, overweight, and obese men. PLoS One. 2012;7:e45748. [PMC free article] [PubMed] [Google Scholar]
82. Cahill F, Shea JL, Randell E, Vasdev S, Sun G. Serum peptide YY in response to short-term overfeeding in young men. Am J Clin Nutr. 2011;93:741–747. [PubMed] [Google Scholar]
83. Numao S, et al. Effects of a single bout of aerobic exercise on short-term low-carbohydrate/high-fat intake-induced postprandial glucose metabolism during an oral glucose tolerance test. Metabolism. 2013;62:1406–1415. [PubMed] [Google Scholar]
84. Drucker DJ. Deciphering metabolic messages from the gut drives therapeutic innovation: the 2014 Banting Lecture. Diabetes. 2015;64:317–326. [PubMed] [Google Scholar]
85. Perry RJ, et al. Acetate mediates a microbiome-brain-beta-cell axis to promote metabolic syndrome. Nature. 2016;534:213–217. [PMC free article] [PubMed] [Google Scholar]
86. Lo JC, et al. Adipsin is an adipokine that improves beta cell function in diabetes. Cell. 2014;158:41–53. [PMC free article] [PubMed] [Google Scholar]
87. Kraegen EW, et al. Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes. 1991;40:1397–1403. [PubMed] [Google Scholar]
88. Abdul-Ghani MA, Jenkinson CP, Richardson DK, Tripathy D, DeFronzo RA. Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study. Diabetes. 2006;55:1430–1435. [PubMed] [Google Scholar]
89. Samuel VT, Shulman GI. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Invest. 2016;126:12–22. [PMC free article] [PubMed] [Google Scholar]
90. Copps KD, White MF. Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2. Diabetologia. 2012;55:2565–2582. [PMC free article] [PubMed] [Google Scholar]
91. Petersen MC, et al. Insulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance. J Clin Invest. 2016;126:4361–4371. [PMC free article] [PubMed] [Google Scholar]
92. Chaurasia B, Summers SA. Ceramides - Lipotoxic Inducers of Metabolic Disorders. Trends Endocrinol Metab. 2015;26:538–550. [PubMed] [Google Scholar]
93. Zhang C, et al. Inhibited insulin signaling in mouse hepatocytes is associated with increased phosphatidic acid but not diacylglycerol. J Biol Chem. 2015;290:3519–3528. [PMC free article] [PubMed] [Google Scholar]
94. Guilherme A, Virbasius JV, Puri V, Czech MP. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol. 2008;9:367–377. [PMC free article] [PubMed] [Google Scholar]
95. Kang S, Tsai LT, Rosen ED. Nuclear Mechanisms of Insulin Resistance. Trends Cell Biol. 2016;26:341–351. [PMC free article] [PubMed] [Google Scholar]
96. Kusminski CM, Bickel PE, Scherer PE. Targeting adipose tissue in the treatment of obesity-associated diabetes. Nat Rev Drug Discov. 2016;15:639–660. [PubMed] [Google Scholar]
97. Newgard CB. Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metab. 2012;15:606–614. [PMC free article] [PubMed] [Google Scholar]
98. Sabio G, Davis RJ. cJun NH2-terminal kinase 1 (JNK1): roles in metabolic regulation of insulin resistance. Trends Biochem Sci. 2010;35:490–496. [PMC free article] [PubMed] [Google Scholar]
99. Hoehn KL, et al. IRS1-independent defects define major nodes of insulin resistance. Cell Metab. 2008;7:421–433. [PMC free article] [PubMed] [Google Scholar]
100. Miinea CP, et al. AS160, the Akt substrate regulating GLUT4 translocation, has a functional Rab GTPase-activating protein domain. Biochem J. 2005;391:87–93. [PMC free article] [PubMed] [Google Scholar]
101. Sun K, et al. Endotrophin triggers adipose tissue fibrosis and metabolic dysfunction. Nat Commun. 2014;5:3485. [PMC free article] [PubMed] [Google Scholar]
102. Barrett EJ, Wang H, Upchurch CT, Liu Z. Insulin regulates its own delivery to skeletal muscle by feed-forward actions on the vasculature. Am J Physiol Endocrinol Metab. 2011;301:E252–263. [PMC free article] [PubMed] [Google Scholar]
103. Lee WL, Klip A. Endothelial Transcytosis of Insulin: Does It Contribute to Insulin Resistance? Physiology (Bethesda) 2016;31:336–345. [PubMed] [Google Scholar]
104. Williams AS, Kang L, Wasserman DH. The extracellular matrix and insulin resistance. Trends Endocrinol Metab. 2015;26:357–366. [PMC free article] [PubMed] [Google Scholar]
105. Williams AS, et al. Integrin alpha1-null mice exhibit improved fatty liver when fed a high fat diet despite severe hepatic insulin resistance. J Biol Chem. 2015;290:6546–6557. [PMC free article] [PubMed] [Google Scholar]
106. Kang L, et al. Diet-induced muscle insulin resistance is associated with extracellular matrix remodeling and interaction with integrin alpha2beta1 in mice. Diabetes. 2011;60:416–426. [PMC free article] [PubMed] [Google Scholar]
107. Kang L, et al. Integrin-Linked Kinase in Muscle Is Necessary for the Development of Insulin Resistance in Diet-Induced Obese Mice. Diabetes. 2016;65:1590–1600. [PMC free article] [PubMed] [Google Scholar]
108. Abdennour M, et al. Association of adipose tissue and liver fibrosis with tissue stiffness in morbid obesity: links with diabetes and BMI loss after gastric bypass. J Clin Endocrinol Metab. 2014;99:898–907. [PubMed] [Google Scholar]
109. Corvera S, Gealekman O. Adipose tissue angiogenesis: impact on obesity and type-2 diabetes. Biochim Biophys Acta. 2014;1842:463–472. [PMC free article] [PubMed] [Google Scholar]
110. Gealekman O, et al. Control of adipose tissue expandability in response to high fat diet by the insulin-like growth factor-binding protein-4. J Biol Chem. 2014;289:18327–18338. [PMC free article] [PubMed] [Google Scholar]
111. Furler SM, Jenkins AB, Storlien LH, Kraegen EW. In vivo location of the rate-limiting step of hexose uptake in muscle and brain tissue of rats. Am J Physiol. 1991;261:E337–347. [PubMed] [Google Scholar]
112. Zierath JR, Krook A, Wallberg-Henriksson H. Insulin action in skeletal muscle from patients with NIDDM. Mol Cell Biochem. 1998;182:153–160. [PubMed] [Google Scholar]
113. Turner N, Cooney GJ, Kraegen EW, Bruce CR. Fatty acid metabolism, energy expenditure and insulin resistance in muscle. J Endocrinol. 2014;220:T61–79. [PubMed] [Google Scholar]
114. Bonadonna RC, et al. Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes. 1996;45:915–925. [PubMed] [Google Scholar]
115. Cline GW, et al. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med. 1999;341:240–246. [PubMed] [Google Scholar]
116. Petersen KF, Shulman GI. Cellular mechanism of insulin resistance in skeletal muscle. J R Soc Med. 2002;95(Suppl 42):8–13. [PMC free article] [PubMed] [Google Scholar]
117. Kelley DE, et al. The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle. J Clin Invest. 1996;97:2705–2713. [PMC free article] [PubMed] [Google Scholar]
118. Williams KV, Price JC, Kelley DE. Interactions of impaired glucose transport and phosphorylation in skeletal muscle insulin resistance: a dose-response assessment using positron emission tomography. Diabetes. 2001;50:2069–2079. [PubMed] [Google Scholar]
119. Perry RJ, Zhang D, Zhang XM, Boyer JL, Shulman GI. Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats. Science. 2015;347:1253–1256. [PMC free article] [PubMed] [Google Scholar]
120. Montgomery MK, Turner N. Mitochondrial dysfunction and insulin resistance: an update. Endocr Connect. 2015;4:R1–r15. [PMC free article] [PubMed] [Google Scholar]
121. Patti ME, Corvera S. The role of mitochondria in the pathogenesis of type 2 diabetes. Endocr Rev. 2010;31:364–395. [PMC free article] [PubMed] [Google Scholar]
122. Czech MP. Cellular basis of insulin insensitivity in large rat adipocytes. J Clin Invest. 1976;57:1523–1532. [PMC free article] [PubMed] [Google Scholar]
123. Kahn BB. Lilly lecture 1995. Glucose transport: pivotal step in insulin action. Diabetes. 1996;45:1644–1654. [PubMed] [Google Scholar]
124. Gonzalez E, Flier E, Molle D, Accili D, McGraw TE. Hyperinsulinemia leads to uncoupled insulin regulation of the GLUT4 glucose transporter and the FoxO1 transcription factor. Proc Natl Acad Sci U S A. 2011;108:10162–10167. [PMC free article] [PubMed] [Google Scholar]
125. Sabio G, et al. A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science. 2008;322:1539–1543. [PMC free article] [PubMed] [Google Scholar]
126. Tan SX, et al. Amplification and demultiplexing in insulin-regulated Akt protein kinase pathway in adipocytes. J Biol Chem. 2012;287:6128–6138. [PMC free article] [PubMed] [Google Scholar]
128. Morley TS, Xia JY, Scherer PE. Selective enhancement of insulin sensitivity in the mature adipocyte is sufficient for systemic metabolic improvements. Nat Commun. 2015;6:7906. [PMC free article] [PubMed] [Google Scholar]
129. Thomson MJ, Williams MG, Frost SC. Development of insulin resistance in 3T3-L1 adipocytes. J Biol Chem. 1997;272:7759–7764. [PubMed] [Google Scholar]
130. Richardson DK, Czech MP. Primary role of decreased fatty acid synthesis in insulin resistance of large rat adipocytes. Am J Physiol. 1978;234:E182–189. [PubMed] [Google Scholar]
131. Czech MP, Tencerova M, Pedersen DJ, Aouadi M. Insulin signalling mechanisms for triacylglycerol storage. Diabetologia. 2013;56:949–964. [PMC free article] [PubMed] [Google Scholar]
132. Herman MA, et al. A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism. Nature. 2012;484:333–338. [PMC free article] [PubMed] [Google Scholar]
133. Tang Y, et al. Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism. Nat Commun. 2016;7:11365. [PMC free article] [PubMed] [Google Scholar]
134. Solinas G, Boren J, Dulloo AG. De novo lipogenesis in metabolic homeostasis: More friend than foe? Mol Metab. 2015;4:367–377. [PMC free article] [PubMed] [Google Scholar]
135. Baraille F, Planchais J, Dentin R, Guilmeau S, Postic C. Integration of ChREBP-Mediated Glucose Sensing into Whole Body Metabolism. Physiology (Bethesda) 2015;30:428–437. [PubMed] [Google Scholar]
136. Lodhi IJ, et al. Inhibiting adipose tissue lipogenesis reprograms thermogenesis and PPARgamma activation to decrease diet-induced obesity. Cell Metab. 2012;16:189–201. [PMC free article] [PubMed] [Google Scholar]
137. Yore MM, et al. Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects. Cell. 2014;159:318–332. [PMC free article] [PubMed] [Google Scholar]
138. Smith U, Kahn BB. Adipose tissue regulates insulin sensitivity: role of adipogenesis, de novo lipogenesis and novel lipids. J Intern Med. 2016;280:465–475. [PMC free article] [PubMed] [Google Scholar]
139. Guilherme A, et al. Adipocyte lipid synthesis coupled to neuronal control of thermogenic programming. Mol Metab. 2017 [PMC free article] [PubMed] [Google Scholar]
140. Dutta A, Abmayr SM, Workman JL. Diverse Activities of Histone Acylations Connect Metabolism to Chromatin Function. Mol Cell. 2016;63:547–552. [PMC free article] [PubMed] [Google Scholar]
141. Wellen KE, Thompson CB. A two-way street: reciprocal regulation of metabolism and signalling. Nat Rev Mol Cell Biol. 2012;13:270–276. [PubMed] [Google Scholar]
142. Londono Gentile T, et al. DNMT1 is regulated by ATP-citrate lyase and maintains methylation patterns during adipocyte differentiation. Mol Cell Biol. 2013;33:3864–3878. [PMC free article] [PubMed] [Google Scholar]
143. Wellen KE, et al. ATP-citrate lyase links cellular metabolism to histone acetylation. Science. 2009;324:1076–1080. [PMC free article] [PubMed] [Google Scholar]
144. McDonnell E, et al. Lipids Reprogram Metabolism to Become a Major Carbon Source for Histone Acetylation. Cell Rep. 2016;17:1463–1472. [PMC free article] [PubMed] [Google Scholar]
145. Lefterova MI, Haakonsson AK, Lazar MA, Mandrup S. PPARgamma and the global map of adipogenesis and beyond. Trends Endocrinol Metab. 2014;25:293–302. [PMC free article] [PubMed] [Google Scholar]
146. Sugii S, Evans RM. Epigenetic codes of PPARgamma in metabolic disease. FEBS Lett. 2011;585:2121–2128. [Google Scholar]
147. Wilson-Fritch L, et al. Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J Clin Invest. 2004;114:1281–1289. [PMC free article] [PubMed] [Google Scholar]
148. Choi JH, et al. Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5. Nature. 2010;466:451–456. [PMC free article] [PubMed] [Google Scholar]
149. Soccio RE, et al. Genetic Variation Determines PPARgamma Function and Anti-diabetic Drug Response In Vivo. Cell. 2015;162:33–44. [PMC free article] [PubMed] [Google Scholar]
150. Soccio RE, et al. Targeting PPARgamma in the epigenome rescues genetic metabolic defects in mice. J Clin Invest. 2017;127:1451–1462. [PMC free article] [PubMed] [Google Scholar]
151. Kienesberger PC, et al. Adipose triglyceride lipase deficiency causes tissue-specific changes in insulin signaling. J Biol Chem. 2009;284:30218–30229. [PMC free article] [PubMed] [Google Scholar]
152. Zechner R. FAT FLUX: enzymes, regulators, and pathophysiology of intracellular lipolysis. EMBO Mol Med. 2015;7:359–362. [PMC free article] [PubMed] [Google Scholar]
153. Kory N, Farese RV, Jr, Walther TC. Targeting Fat: Mechanisms of Protein Localization to Lipid Droplets. Trends Cell Biol. 2016;26:535–546. [PMC free article] [PubMed] [Google Scholar]
154. Krahmer N, Farese RV, Jr, Walther TC. Balancing the fat: lipid droplets and human disease. EMBO Mol Med. 2013;5:973–983. [PMC free article] [PubMed] [Google Scholar]
155. Degerman E, et al. Phosphorylation and activation of hormone-sensitive adipocyte phosphodiesterase type 3B. Methods. 1998;14:43–53. [PubMed] [Google Scholar]
156. Choi YH, et al. Alterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B-null mice. J Clin Invest. 2006;116:3240–3251. [PMC free article] [PubMed] [Google Scholar]
157. Kitamura T, et al. Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt. Mol Cell Biol. 1999;19:6286–6296. [PMC free article] [PubMed] [Google Scholar]
158. Choi SM, et al. Insulin regulates adipocyte lipolysis via an Akt-independent signaling pathway. Mol Cell Biol. 2010;30:5009–5020. [PMC free article] [PubMed] [Google Scholar]
159. Koren S, et al. The role of mouse Akt2 in insulin-dependent suppression of adipocyte lipolysis in vivo. Diabetologia. 2015;58:1063–1070. [PMC free article] [PubMed] [Google Scholar]
160. DiPilato LM, et al. The Role of PDE3B Phosphorylation in the Inhibition of Lipolysis by Insulin. Mol Cell Biol. 2015;35:2752–2760. [PMC free article] [PubMed] [Google Scholar]
161. Shin AC, et al. Insulin Receptor Signaling in Pomc, but not Agrp, Neurons Controls Adipose Tissue Insulin Action. Diabetes. 2017 [PMC free article] [PubMed] [Google Scholar]
162. Vigneri R, Goldfine ID, Frittitta L. Insulin, insulin receptors, and cancer. J Endocrinol Invest. 2016;39:1365–1376. [PubMed] [Google Scholar]
163. Zierler KA, et al. Functional cardiac lipolysis in mice critically depends on comparative gene identification-58. J Biol Chem. 2013;288:9892–9904. [PMC free article] [PubMed] [Google Scholar]
164. Whiteman EL, Cho H, Birnbaum MJ. Role of Akt/protein kinase B in metabolism. Trends Endocrinol Metab. 2002;13:444–451. [PubMed] [Google Scholar]
165. Cho H, et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta) Science. 2001;292:1728–1731. [PubMed] [Google Scholar]
166. Jiang ZY, et al. Insulin signaling through Akt/protein kinase B analyzed by small interfering RNA-mediated gene silencing. Proc Natl Acad Sci U S A. 2003;100:7569–7574. [PMC free article] [PubMed] [Google Scholar]
167. Leavens KF, Easton RM, Shulman GI, Previs SF, Birnbaum MJ. Akt2 is required for hepatic lipid accumulation in models of insulin resistance. Cell Metab. 2009;10:405–418. [PMC free article] [PubMed] [Google Scholar]